Post-Marketing Observational Study to Evaluate Safety Profile of Avamys Treatment in Chinese Patients

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-17013719

Enrollment

Unknown

Registered

2017-12-06

Start date

2016-11-30

Completion date

Unknown

Last updated

2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Unlimited

Interventions

Case series:Avamys

Eligibility

Sex/Gender

All

Age

2 Years to No maximum

Inclusion criteria

Inclusion criteria: Subjects who have been prescribed Avamys for appropriate medical use.

Exclusion criteria

Exclusion criteria: No ICF

Design outcomes

Primary

Measure	Time frame
Adverse evevt;	—

Countries

China

Contacts

Public ContactYun-tao Jia

Children's Hospital of Chongqing Medical University

32233125@qq.com+86 023-63625666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026